<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The complex and largely obscure regulatory processes that underlie ossification and fusion of the sutures during skull morphogenesis are dependent on the conditions of the extracellular microenvironment </plain></SENT>
<SENT sid="1" pm="."><plain>The concept that growth factors are involved in the pathophysiology of <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> due to premature fusion of skull bone sutures, is supported by recent genetic data </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndromes</z:e>, for example, are characterized by point mutations in the extracellular or transmembrane domains of fibroblast growth factor-2 receptor </plain></SENT>
<SENT sid="3" pm="."><plain>In primary cultures of periosteal fibroblasts and osteoblasts obtained from <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> and <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> patients, we observed that <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> cells behaved differently with respect to <z:mpath ids='MPATH_458'>normal</z:mpath> cells as regards the expression of cytokines and extracellular matrix (ECM) <z:chebi fb="4" ids="33839">macromolecule</z:chebi> accumulation </plain></SENT>
<SENT sid="4" pm="."><plain>Further modulation of ECM components observed after the addition of cytokines provides support for an autocrine involvement of these cytokines in <z:e sem="disease" ids="C0010273" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Crouzon</z:e> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> phenotype </plain></SENT>
<SENT sid="5" pm="."><plain>Changes in ECM composition could explain the altered osteogenic process and account for pathological variations in cranial development </plain></SENT>
<SENT sid="6" pm="."><plain>We suggest that a correlation exists between in vitro phenotype, clinical features and genotype in the two craniosynostotic syndromes </plain></SENT>
<SENT sid="7" pm="."><plain>New research into signal transduction pathways should establish further connections between the mutated genotype and the molecular biology of the <z:mp ids='MP_0005384'>cellular phenotype</z:mp> </plain></SENT>
</text></document>